Literature DB >> 28404114

Functional gastrointestinal disorders: what's new for Rome IV?

Douglas A Drossman1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 28404114     DOI： 10.1016/S2468-1253(16)30022-X

Source DB:  PubMed          Journal:  Lancet Gastroenterol Hepatol


× No keyword cloud information.
  10 in total

Review 1.  American Gastroenterological Association Institute Technical Review on the Medical Management of Opioid-Induced Constipation.

Authors:  Brian Hanson; Shazia Mehmood Siddique; Yolanda Scarlett; Shahnaz Sultan
Journal:  Gastroenterology       Date:  2018-10-16       Impact factor: 22.682

2.  Improving the Treatment of Irritable Bowel Syndrome With the Rome IV Multidimensional Clinical Profile.

Authors:  Douglas A Drossman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-11

3.  Symptom Severity Following Rifaximin and the Probiotic VSL#3 in Patients with Chronic Pelvic Pain Syndrome (Due to Inflammatory Prostatitis) Plus Irritable Bowel Syndrome.

Authors:  Enzo Vicari; Michele Salemi; Giuseppe Sidoti; Mariano Malaguarnera; Roberto Castiglione
Journal:  Nutrients       Date:  2017-11-03       Impact factor: 5.717

4.  Fecal dysbiosis associated with colonic hypersensitivity and behavioral alterations in chronically Blastocystis-infected rats.

Authors:  Frédéric Antonio Carvalho; Philippe Poirier; Manon Defaye; Céline Nourrisson; Elodie Baudu; Amandine Lashermes; Maëva Meynier; Mathieu Meleine; Ivan Wawrzyniak; Virginie Bonnin; Julie Barbier; Benoit Chassaing; Catherine Godfraind; Agathe Gelot; Nicolas Barnich; Denis Ardid; Mathilde Bonnet; Frédéric Delbac
Journal:  Sci Rep       Date:  2020-06-04       Impact factor: 4.379

5.  Abdominal pain in patients with inflammatory bowel disease: association with single-nucleotide polymorphisms prevalent in irritable bowel syndrome and clinical management.

Authors:  Martina Ledergerber; Brian M Lang; Henriette Heinrich; Luc Biedermann; Stefan Begré; Jonas Zeitz; Niklas Krupka; Andreas Rickenbacher; Matthias Turina; Thomas Greuter; Philipp Schreiner; René Roth; Alexander Siebenhüner; Stephan R Vavricka; Gerhard Rogler; Niko Beerenwinkel; Benjamin Misselwitz
Journal:  BMC Gastroenterol       Date:  2021-02-05       Impact factor: 3.067

Review 6.  Uncovering the pathophysiology of irritable bowel syndrome by exploring the gut-brain axis: a narrative review.

Authors:  He-Yong Tang; Ai-Juan Jiang; Xi-Yang Wang; Hao Wang; Yuan-Yuan Guan; Fei Li; Guo-Ming Shen
Journal:  Ann Transl Med       Date:  2021-07

7.  Alteration of Serum Metabolites in Women of Reproductive Age with Chronic Constipation.

Authors:  Shuai Liu; Chuanli Yang; Hongxia Li; Xinshu Bai; Tianjiao Hu; Xin Xue; Jie An; Yan Zhang; Xiushan Dong
Journal:  Med Sci Monit       Date:  2022-03-03

Review 8.  Supragastric belching: Pathogenesis, diagnostic issues and treatment.

Authors:  Stefan L Popa; Teodora Surdea-Blaga; Liliana David; Mihaela Fadgyas Stanculete; Alina Picos; Dan L Dumitrascu; Giuseppe Chiarioni; Abdulrahman Ismaiel; Dinu I Dumitrascu
Journal:  Saudi J Gastroenterol       Date:  2022 May-Jun       Impact factor: 3.214

9.  Diet or medication in primary care patients with IBS: the DOMINO study - a randomised trial supported by the Belgian Health Care Knowledge Centre (KCE Trials Programme) and the Rome Foundation Research Institute.

Authors:  Florencia Carbone; Karen Van den Houte; Linde Besard; Céline Tack; Joris Arts; Philip Caenepeel; Hubert Piessevaux; Alain Vandenberghe; Christophe Matthys; Jessica Biesiekierski; Luc Capiau; Steven Ceulemans; Olivier Gernay; Lydia Jones; Sophie Maes; Christian Peetermans; Willem Raat; Jeroen Stubbe; Rudy Van Boxstael; Olivia Vandeput; Sophie Van Steenbergen; Lukas Van Oudenhove; Tim Vanuytsel; Michael Jones; Jan Tack
Journal:  Gut       Date:  2022-04-28       Impact factor: 31.793

10.  Efficacy of a low-FODMAP diet in adult irritable bowel syndrome: a systematic review and meta-analysis.

Authors:  Anne-Sophie van Lanen; Angelika de Bree; Arno Greyling
Journal:  Eur J Nutr       Date:  2021-02-14       Impact factor: 5.614
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.